The World Endoscopy Organization (WEO) released a vital international consensus statement on the legal and ethical framework for AI in Endoscopy. This consensus emerged from a Delphi study involving international experts who prioritized key concerns for clinical integration. The OperA project (Optimising Colorectal Cancer Prevention through Personalized Treatment with Artificial Intelligence) aims to transform GI care; consequently, addressing legal and ethical challenges remains a primary obstacle. Therefore, this statement provides a foundational structure for developing responsible guidelines in gastroenterology.
Core Ethical and Legal Domains for AI in Endoscopy
Experts reached a consensus on ten key statements across three thematic domains: data governance, medicolegal implications, and equity and bias. Data governance requires robust protection. Institutions must clarify data ownership. Algorithmic development must remain transparent. Moreover, the Central Drugs Standard Control Organization (CDSCO) in India is actively developing specific guidelines for AI medical devices, classifying them based on risk. This evolving regulatory landscape demands attention from all Indian gastroenterologists. Consequently, clinicians must stay current with pre-market approval and post-market surveillance requirements.
Navigating Medicolegal Implications and Liability
Liability concerns related to AI-assisted diagnosis and automated reporting were heavily highlighted by the expert panel. Furthermore, traditional legal systems were not designed for autonomous decision-making technologies. In India, the Consumer Protection Act, 2019, considers medical services as ‘services’ and patients as ‘consumers,’ allowing claims against manufacturers of defective AI systems. However, determining who is responsible—the doctor, the AI developer, or the hospital—when a wrong diagnosis occurs presents a complex challenge. Therefore, legal and professional bodies must offer clear guidance. The Indian Council of Medical Research (ICMR) has published guidelines emphasizing patient safety, algorithmic transparency, and accountability, which provide a critical starting point. Clinicians must ensure informed consent is obtained, where patients understand the level of AI integration in their treatment.
Addressing Equity and Bias in AI in Endoscopy
A major ethical concern involves equity and bias in AI deployment. Participants emphasized the crucial importance of demographic diversity in training data sets. Transparent reporting practices are also necessary to mitigate bias and ensure equitable deployment. For instance, AI models developed on diverse international populations may perform differently in the diverse Indian population. Reduced performance can be observed when applied to under-represented patient subgroups. Therefore, local validation of AI models remains essential, particularly in resource-constrained settings in India. This ensures cost-effectiveness and prevents AI from aggravating existing systemic healthcare burdens.
Frequently Asked Questions
Q1: What are the three key domains of the AI in Endoscopy consensus statement?
The three domains are data governance, medicolegal implications (liability), and equity and bias.
Q2: How does the consensus statement relate to liability in an AI-assisted diagnosis?
The statement highlights liability concerns related to AI-assisted diagnosis and automated reporting, calling for clear guidance from legal and professional bodies to address the complexity of assigning responsibility among the AI developer, clinician, and institution.
References
- Ahmad OF et al. The Legal and Ethical Framework for Artificial Intelligence in Gastrointestinal Endoscopy: A World Endoscopy Organization International Consensus Statement. Ann Intern Med. 2025 Dec 09. doi: 10.7326/ANNALS-25-03415. PMID: 41359967.
- Maheshwari & Co. AI Medical Device Compliance Bhopal: Act Now! The Evolving Regulatory Landscape for AI in Indian Healthcare. Prospect Legal.
- Dey A. Artificial Intelligence in Gastrointestinal Endoscopy in a Resource-constrained Setting: A Reality Check. Euroasian J Hepato-Gastroenterol. 2020 Jul-Dec;10(2):95-98. doi: 10.5005/jp-journals-10018-1327.